Akèy › Sendwòm myelodisplastik › Illinois › Peoria
Etid klinik pou Sendwòm myelodisplastik nan Peoria, IL
4 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Peoria (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi lwen
- Illinois CancerCare-Canton, Canton · 25 mi lwen
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- OSF Saint Francis Medical Center, Peoria
- ak 2 plis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- OSF Children's Hospital of Illinois, Peoria
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Ap rekriteFaz 3
- ILCC. Illinois Cancer Centers, Peoria
Etid Sendwòm myelodisplastik nan lòt vil
- Houston, TX43 etid
- Baldwin Park, CA26 etid
- New York City, NY21 etid
- Seattle, WA21 etid
- Washington, DC20 etid
- Boston, MA19 etid
- Tampa, FL19 etid
- Miami, FL17 etid
- Columbus, OH14 etid
- Durham, NC14 etid
- Chicago, IL13 etid
- Atlanta, GA13 etid
Lòt etid nan Peoria
- Kansè Poumon ki pa ti selil21 etid
- Kansè poumon12 etid
- Kansè kolorektal12 etid
- Kansè pwostat9 etid
- Ensifizyans kadyak8 etid
- Kansè nan tete8 etid
- Kansè ovè7 etid
- Karsinòm selil skuamèz tèt ak kou7 etid
- Kansè Metastatik7 etid
- Kansè pankreyas7 etid
- Kansè (tout kalite)7 etid
- Melanom6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.